Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines

被引:0
|
作者
H. Okada
T. A. Sato
A. Katayama
K. Higuchi
K. Shichijo
T. Tsuchiya
N. Takayama
Y. Takeuchi
T. Abe
N. Okabe
M. Tashiro
机构
[1]  Department of Viral Diseases and Vaccine Control,
[2] National Institute of Infectious Diseases,undefined
[3] Tokyo,undefined
[4] Japan,undefined
[5]  Infectious Disease Surveillance Center,undefined
[6] National Institute of Infectious Diseases,undefined
[7] Tokyo,undefined
[8] Japan,undefined
[9]  Katayama Children’s Clinic,undefined
[10] Yokohama,undefined
[11] Japan,undefined
[12]  Higuchi Pediatric Clinic,undefined
[13] Yokohama,undefined
[14] Japan,undefined
[15]  Shichijo Pediatric Clinic,undefined
[16] Tokyo,undefined
[17] Japan,undefined
[18]  Tsuchiya Pediatric Clinic,undefined
[19] Kuki City,undefined
[20] Saitama,undefined
[21] Japan,undefined
[22]  Komagome Metropolitan Hospital,undefined
[23] Tokyo,undefined
[24] Japan,undefined
[25]  Kawasaki Municipal Hospital,undefined
[26] Kawasaki,undefined
[27] Japan,undefined
来源
Archives of Virology | 2001年 / 146卷
关键词
Measle; Lymphopenia; Measle Virus; Measle Vaccine; Vaccine Recipient;
D O I
暂无
中图分类号
学科分类号
摘要
 Measles virus infection induces a profound immunosuppression. We analyzed in a time-dependent manner peripheral bloods of one to two-year-old children immunized with live attenuated measles vaccines, compared with age-matched measles patients, for immunosuppression. In contrast to transient severe lymphopenia with measles patients, primarily due to extensive apoptosis of a broad spectrum of uninfected lymphocytes, neither apoptosis nor lymphopenia occurred with measles vaccine recipients. Increase in number and activation of NK cells, which might compensate for the lymphopenia in measles patients, were not found with the vaccinees. While cell surface expression of apoptosis-related molecules such as TNF-related apoptosis-inducing ligand (TRAIL), TRAIL-receptors, CD95(Fas) and Fas-ligand, and plasma interferon-γ were increased for measles patients, they remained unchanged after vaccination. Plasma interleukin (IL)-18, which is responsible for inducing apoptosis in several infectious diseases, was increased predominantly with measles patients, whereas the increase remained marginal with the vaccinees. IL-10 was elevated transiently in both measles patients and vaccinees. Decrease in plasma IL-12, which is often correlated with T cell suppression, was not found for both cases. Serum IgM and IgG antibodies to measles virus were induced at lower titers in the vaccinees than measles patients. These results indicate that in contrast to wild-type measles virus, live measles vaccines hardly provoked host cytokine responses that lead to apoptotic cytolysis of uninfected lymphocytes, lymphopenia and immunosuppression, and thereby induced weaker immune responses to the virus.
引用
收藏
页码:859 / 874
页数:15
相关论文
共 38 条
  • [31] An equity-based assessment of immunization-related responses in urban Alberta during the 2014 measles outbreak: a comparative analysis between Calgary and Edmonton
    Bandara, Thilina
    Neudorf, Cory
    Muhajarine, Nazeem
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2022, 113 (03): : 422 - 432
  • [32] Live-Attenuated Viral Vaccines May Alter Within- and Between-Host Dynamics of Non-Vaccine Targeted Bacterial Pathogens
    Mina, Michael
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S163 - S164
  • [33] Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children
    Levin, Myron J.
    Song, Lin-Ye
    Fenton, Terrence
    Nachman, Sharon
    Patterson, Julie
    Walker, Robert
    Kemble, George
    Allende, Maria
    Hultquist, Micki
    Yi, Tingting
    Nowak, Barbara
    Weinberg, Adriana
    VACCINE, 2008, 26 (33) : 4210 - 4217
  • [34] A measles outbreak in Kansai International Airport, Japan, 2016: Analysis of the quantitative difference and infectivity of measles virus between patients who are immunologically naive versus those with secondary vaccine failure
    Kurata, Takako
    Yamamoto, Seiji P.
    Nishimura, Hiroshi
    Yumisashi, Takahiro
    Motomura, Kazushi
    Kinoshita, Masaru
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (06) : 3446 - 3454
  • [35] A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9-12 month old healthy infants
    Thuluva, Subhash
    Gunneri, SubbaReddy
    Turaga, Kishore
    Mogulla, Rammohan Reddy
    Yerroju, Vijay
    Peta, Kalyankumar
    Suneetha, Pothakamuri Venkata
    Matur, Ramesh V.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 36
  • [36] Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model
    Bodmer, Bianca S.
    Fiedler, Anna H.
    Hanauer, Jan R. H.
    Pruefer, Steffen
    Muehlebach, Michael D.
    VIROLOGY, 2018, 521 : 99 - 107
  • [37] Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naive horses and pretreated horses with the live-attenuated African horse sickness vaccine
    Chaiyabutr, Narongsak
    Wattanaphansak, Suphot
    Tantilerdcharoen, Rachod
    Akesowan, Surasak
    Ouisuwan, Suraseha
    Naraporn, Darm
    VETERINARY WORLD, 2022, 15 (10) : 2365 - 2375
  • [38] Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients.
    Nakazawa, Hideyuki
    Sakai, Kaoko
    Sudo, Yuriko
    Iwabuchi, Ryohei
    Sakai, Hitoshi
    Nishina, Sayaka
    Kawakami, Toru
    Kawakami, Fumihiro
    Matsuzawa, Shuji
    Ito, Toshiro
    Kitahara, Mari
    Kamijo, Yuji
    Umemura, Takeji
    Ushiki, Atsuhito
    Kanai, Shinichiro
    Tsuchiya, Hiroyuki
    Ishida, Fumihiro
    TRANSPLANT IMMUNOLOGY, 2022, 75